RECRUITING

QL Block in Laparoscopic Myomectomy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.

Official Title

Quadratus Lumborum Block to Improve Postoperative Pain Management After Laparoscopic Myomectomies: a Double-blinded and Prospective Randomized Clinical Trial.

Quick Facts

Study Start:2024-08-24
Study Completion:2025-07-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05979493

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Presence of uterine fibroids requiring surgical excision with preservation of the uterus
  2. * Stated willingness to comply with all study procedures and availability for the duration of the study
  3. * Provision of signed and dated informed consent form
  1. * Pre-existing diagnoses of anxiety or depression
  2. * Pre-existing coagulopathies
  3. * Pre-existing neuropathic or chronic pelvic pain
  4. * Chronic opioid use
  5. * Illiteracy due to inability to read and understand plain questionnaire
  6. * Non-English speaking
  7. * BMI \>38

Contacts and Locations

Study Contact

Catherine P Haering, BA
CONTACT
3392011531
cph43@case.edu

Principal Investigator

Joseph Findley, MD
PRINCIPAL_INVESTIGATOR
University Hospitals

Study Locations (Sites)

University Hospitals Ahuja Medical Center
Beachwood, Ohio, 44122
United States

Collaborators and Investigators

Sponsor: Joseph Findley MD

  • Joseph Findley, MD, PRINCIPAL_INVESTIGATOR, University Hospitals

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-24
Study Completion Date2025-07-03

Study Record Updates

Study Start Date2024-08-24
Study Completion Date2025-07-03

Terms related to this study

Keywords Provided by Researchers

  • QL Block
  • Myomectomy

Additional Relevant MeSH Terms

  • Postoperative Pain
  • Fibroid Uterus